PointCross Releases eDataValidator for SDTM, ADaM, SEND, and Define.XML Conformance to Prevailing FDA, CDISC, and PMDA Rules
20. Juli 2022 09:00 ET
|
PointCross Life Sciences
FOSTER CITY, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- PointCross Life Sciences announced today the full complement release of its eDataValidator™ (eDV) for validating SDTM, ADaM, SEND and...
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021
07. Dezember 2021 16:03 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Completes Purchase of Envigo
05. November 2021 13:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind. and INDIANAPOLIS, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (or “Inotiv”), a leading contract research organization (CRO) specializing in nonclinical and...
Inotiv, Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purchase Additional $15 Million of Notes
27. September 2021 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering
22. September 2021 18:34 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering
21. September 2021 17:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical...
Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions
21. September 2021 09:00 ET
|
Inotiv, Inc.
-- Expected to establish a leading global provider of a full spectrum of pre-clinical solutions -- -- Expected to be immediately accretive to Inotiv earnings and margins before synergies -- --...
Inotiv, Inc. Announces Third Quarter Fiscal 2021 Financial Results
11. August 2021 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio
12. Juli 2021 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 12, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort
28. Juni 2021 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., June 28, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...